Search the MBS

Prostate, radioactive seed implantation of, urological component, using transrectal ultrasound guidance:

(a) for a patient with:

(i) localised prostatic malignancy at clinical stages T1 (clinically inapparent tumour not palpable or visible by imaging) or T2 (tumour confined within prostate); and

(ii) a Gleason score of less than or equal to 7 (Grade Group 1 to Grade Group 3); and

(iii) a prostate specific antigen (PSA) of not more than 10ng/ml at the time of diagnosis; and

(b) performed by a urologist at an approved site in association with a radiation oncologist; and

(c) being a service associated with:

(i) services to which items 15966 and 55603 apply; and

(ii) a service to which item 60506 or 60509 applies

(H)

Multiple Operation Rule

Fee: $1,189.60 Benefit: 75% = $892.20

(See para TN.8.55 of explanatory notes to this Category)

• Previous - Item 37219
• Next - Item 37221